Expana changes the monthly assessment schedule for certain Plant-Based Protein EBP
March 31, 2025
Expana has changed the assessment schedule for some of its US-based Plant-Based Protein Expana Benchmark Prices (EBP) from Monday, March 31st, 2025, onwards.
The initial proposal was announced in a market note published on January 8, 2025, which can be viewed here and the decision note to go ahead with the schedule change was published on February 16, 2025, and can be viewed here.
The changes are as follows:
· The monthly US-based Plant-Based Protein EBP will be assessed on the last business day of every month at 16:00 US Eastern Time.
The schedule change will bring the assessment in line with the region they are assessed in. Full details of our methodology, including the public holidays observed in the Americas, can be found in the Expana Publishing Schedule available here.
A full list of the affected US Plant-Based Protein EBP is as follows:
|
Assessment Name |
Code |
Description |
|
Soy Protein Concentrate EXW North America |
SCA1 |
Soy protein; Concentrate; Protein content: Min. 65%; Non-GMO; Food grade; Expana Benchmark Prices (EBP) |
|
Soy Protein Texturized Concentrate EXW North America |
SCA2 |
Soy protein; Texturized concentrate; Texturized protein content: Min. 65%; Non-GMO; Food grade; Expana Benchmark Prices (EBP) |
|
Soy Protein Isolate EXW North America |
SIA1 |
Soy protein; Isolate; Protein content: 80-90%; Non-GMO; Food grade; Expana Benchmark Prices (EBP) |
|
Pea Protein Concentrate EXW North America |
PCA1 |
Pea protein; Concentrate; Protein content: Min. 55%; Non-GMO; Food grade; Expana Benchmark Prices (EBP) |
|
Pea Protein Texturized Concentrate EXW North America |
PCA2 |
Pea protein; Texturized concentrate; Texturized protein content: Min. 55%; Non-GMO; Food grade; Expana Benchmark Prices (EBP) |
|
Pea Protein Isolate EXW North America |
PIA1 |
Pea protein; Isolate; Protein content: 80-85%; Non-GMO; Food grade; Expana Benchmark Prices (EBP) |
Please send any questions or comments about this market note to [email protected] and clearly state which market note your comments relate to, and if comments are intended for publication by Expana.
Expana will acknowledge receipt of all comments by email.